Compare TPCS & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TPCS | MDAI |
|---|---|---|
| Founded | 1956 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.1M | 53.8M |
| IPO Year | 2008 | 2021 |
| Metric | TPCS | MDAI |
|---|---|---|
| Price | $5.90 | $1.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 24.6K | ★ 176.9K |
| Earning Date | 02-17-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 41.38 | ★ 65.88 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $31,644,000.00 | $19,650,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $23.50 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.88 | $1.18 |
| 52 Week High | $5.80 | $2.97 |
| Indicator | TPCS | MDAI |
|---|---|---|
| Relative Strength Index (RSI) | 79.11 | 51.45 |
| Support Level | $4.41 | $1.62 |
| Resistance Level | N/A | $1.77 |
| Average True Range (ATR) | 0.21 | 0.09 |
| MACD | 0.07 | 0.02 |
| Stochastic Oscillator | 100.00 | 71.43 |
Techprecision Corp manufactures precision, large-scale fabricated and machined metal structural components and systems. The company provides end-to-end services, transforming raw materials into precision finished products through custom fabrication, precision machining, assembly, integration, inspection, non-destructive evaluation, and testing. It manufactures products in accordance with customers' drawings and specifications while complying with applicable national and international industry codes and standards. Its segments are: Ranor, which generates the majority of revenue, and Stadco, both focused on the manufacture and assembly of components mainly for defense and other precision industrial customers.
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.